Target intelligence / Profile preview

Passive antibody transfer

01

Overview

"Passive antibody transfer" is **not a molecule or receptor**, but rather a process in which preformed antibodies are given to an individual to provide immediate, short-term immunity against specific pathogens or toxins. This can occur naturally—such as maternal IgG transferred to the fetus via the placenta—or artificially through administration of antibody-containing products like immune globulin or monoclonal antibodies[1][2][3]. The process does not stimulate the recipient's own immune system to produce memory cells; thus, protection is temporary and wanes within weeks to months. Passive antibody transfer is used for rapid prophylaxis in cases such as exposure to infectious diseases or for individuals with immunodeficiencies. Notable risks include hypersensitivity reactions and serum sickness when using animal-derived products[1]. Because it describes an **immunological intervention** rather than a discrete molecular entity, it should not be classified as a therapeutic target such as a receptor, enzyme, transporter, etc.[1][3]

Other names
Passive immunityAntibody transferAdoptive immunization
02

Mechanism of action

Direct neutralization of pathogens or toxins by transferred antibodies[1][3]

03

Biological functions

Immune responseInfection prevention
04

Disease associations

InfectionImmunodeficiency
05

Safety considerations

Hypersensitivity reactions (e.g., serum sickness, especially with non-human antibodies)[1]Short duration of protection[1][3]
06

Interacting drugs

Immunoglobulin preparations (IVIG, IG)

1 more in the full profile.

Beyond the preview

Go deeper on Passive antibody transfer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Passive antibody transfer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call